Skip to content

Gerald Exil, MD

NPI 1023125721ActiveIndividual· Pediatrics, Neurodevelopmental Disabilities· Warwick, RI

Pediatrics, Neurodevelopmental Disabilities (MD) in Warwick, Rhode Island, licensed in RI, with an NPI issued in August 2006. Part D covered 29 prescriptions written in 2024, 97% of them generic. Neurelis, Inc. reported $57.17 in payments in 2025, mostly food and beverage.

Overview

NPI1023125721
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedAug 25, 2006
Last updated in NPPESOct 3, 2013

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Neurodevelopmental Disabilities Primary2080P0008XRI8936RI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)29 · 70 30-day fills
Total drug cost$2,168
Generic share97% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$57.17 · 3 payments from 1 company
  • 2024$16.72 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Neurelis, Inc.$57.173

What the 2025 payments were for

  • Food and Beverage$57.17 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records